Invesaro

Stocks CSTE Financial statements

Financial statements

Caesarstone Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Caesarstone Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue539588576546486644691565443397
Cost of revenue326391412397352472528473347324
Gross profit21219716314913417116391.996.773.3
Research and development3.294.163.644.153.974.224.15.094.955.67
Selling and marketing70.381.874.866.86285.794.482.286.279.5
General and administrative40.245.943.340.739.150.851.649.539.139.5
Operating expenses120157131124111144222180139199
Operating income92.840.532.824.722.527.4-58.7-88-41.9-126
Interest expense2.040.350.380.30.07
Interest income0.151.041.471.020.660.150.021.474.83.15
Other non-operating income-3.32-5.58-3.64-5.58-10.2-7.593.081.07-0.01-7.77
Pre-tax income89.53529.119.112.319.8-55.6-87-41.9-133
Income tax137.44.566.244.71.950.7621.31.084.28
Net income to minority interests07.27000
Net income74.626.224.412.97.2219-57.1-108-42.8-137
EBITDA12170.561.453.35262.8-22.3-58-24.8-112
EPS, basic2.080.730.720.370.210.51-1.66-3.13-1.13-3.98
EPS, diluted2.080.730.720.370.210.51-1.66-3.13-1.13-3.98
Shares, basic (weighted)34.734.334.434.434.434.534.534.534.534.6
Shares, diluted (weighted)34.834.434.434.534.534.634.534.534.534.6

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents10613993.613911474.352.154.657.358.4
Short-term investments8.1111.27.080
Receivables63.173.372.678.384.882.877.966.946.948.3
Inventory10113315812315220523813611394.3
Other current assets5.586.186.399.967.97.839.443.695.171.71
Total current assets310378350374386409408320348253
Property, plant and equipment22321721320522322116912375.730.1
Lease right-of-use assets72124155144120115105
Goodwill35.73735.335.247.545.8000
Intangible assets4.552.2412.19.638.826.260.260
Long-term investments10.98.650
Total assets585653617704821868753580549398
Accounts payable48.66455.853.155.181.462.242.852.837.8
Accrued liabilities7.016.066.145.877.8610.5128.837.998.08
Short-term debt8.544.197.57011.112.526.123.924.326.9
Total current liabilities93.3127111126157183165121152138
Long-term debt113143124114107
Lease liabilities64.6113143124114107106
Total liabilities147183150226334373332265277259
Total debt11.216614713813226.9
Paid-in capital147152154157160162163164167168
Retained earnings33135636136837137831220416527
Treasury stock-39.4-39.4-39.4-39.4-39.4-39.4-39.4-39.4-39.4-39.4
Other comprehensive income-1.150.68-3.18-3.291.08-0.7-9.58-8.4-14.9-10.9
Shareholders' equity438470467478487494421315272139
Total equity438470467478487494421315272139
Total liabilities and equity585653617704821868753580549398
Shares outstanding34.334.334.434.434.434.534.534.534.534.6

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income76.527.624.612.97.6217.9-56.4-108-43-138
Depreciation and amortization28.329.928.628.629.535.436.33017.114.2
Stock-based compensation3.075.281.683.632.861.851.51.032.041.2
Deferred income tax-0.96-6.38-3.06-1.51-0.9-4.47-6.0711.9-0.42-1.37
Change in receivables-4.18-7.57-2.64-5.036.070.822.6111.818.70.09
Change in inventory-5.38-27.8-30.635.30.31-54.2-40.910220.121.1
Change in payables1.4213.9-16.2-6.66-17.928.3-21-29.58.95-15.3
Cash from operations1026114.78347.620.7-23.366.531.9-38
Capital expenditures-22.9-22.7-21-23.6-19.8-31.5-17.8-11.2-10.4-9.04
Acquisitions0-290-2.250-1.560
Purchases of investments0-24.5-11.700
Sales and maturities of investments05.2710.412.47.100
Cash from investing-23.3-22.8-21.2-23.6-68.3-34.9-7.29-40.5-24.442
Dividends paid-0.24-20.3-5.16-4.82-10.7-8.6300
Cash from financing-35.6-6.27-38.4-14.1-6.08-25.39.16-23.8-3.05-3.88
Exchange rate effect0.930.45-0.320.481.65-0.48
Net change in cash43.532.4-45.145.8-25.1-39.9-22.22.542.711.1
Free cash flow78.638.3-6.2759.527.8-10.8-41.155.421.5-47.1
Interest paid0.210.260.36001.921.160.720.550.28
Income taxes paid17.723.413.910.23.687.384.971.853.120.55

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.94 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin18.4%Gross profit / revenue.
Operating margin-31.6%Operating income / revenue.
EBITDA margin-28.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-33.6%Pre-tax income / revenue.
Net margin-34.6%Net income / revenue.
FCF margin-11.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-9.6%Cash from operations / revenue.
Return on equity (ROE)-66.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-29.0%Net income / average total assets.
Return on invested capital (ROIC)-43.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue1.4%Research and development expense / revenue.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.3%Capital expenditures / revenue.
D&A / revenue3.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-10.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-16.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-4.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-24.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-23.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-11.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-219.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-319.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-48.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-30.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-22.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-27.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-19.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-13.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.83xCurrent assets / current liabilities.
Quick ratio0.77x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.42x(Cash + short-term investments) / current liabilities.
Debt / equity0.19xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets6.8%Total debt / total assets.
Liabilities / assets65.1%Total liabilities / total assets.
Net debt-$31.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-1,822xOperating income / interest expense.
Working capital$114.9MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.0%(Goodwill + intangible assets) / total assets.
Tangible book value$139.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.84xRevenue / average total assets.
Fixed asset turnover7.50xRevenue / average property, plant and equipment.
Inventory turnover3.13xCost of revenue / average inventory.
Days inventory117 days365 x average inventory / cost of revenue.
Receivables turnover8.35xRevenue / average receivables.
Days sales outstanding44 days365 x average receivables / revenue.
Days payables51 days365 x average accounts payable / cost of revenue.
Cash conversion cycle109 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.98Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$3.98Net income per basic share, as reported (split-adjusted).
Revenue per share$11.49Revenue / diluted weighted shares.
FCF per share-$1.36Free cash flow / diluted weighted shares.
Operating cash flow per share-$1.10Cash from operations / diluted weighted shares.
Book value per share$4.03Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$4.03Tangible book value / shares outstanding.
Cash per share$1.69(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$101.7MShare price x shares outstanding.
Enterprise value$70.1MMarket cap + total debt - cash - short-term investments.
P/S0.26xMarket cap / revenue.
P/B0.73xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.73xMarket cap / tangible book value, when positive.
EV/Sales0.18xEnterprise value / revenue.
FCF yield-46.3%Free cash flow / market cap.
Earnings yield-135.2%Net income / market cap (the inverse of P/E).
What was Caesarstone Ltd.'s revenue in fiscal 2025?

Caesarstone Ltd. reported revenue of $397.2M for fiscal 2025, 10.4% lower than the year before.

Was Caesarstone Ltd. profitable in fiscal 2025?

No. It reported a net loss of $137.5M.

How much free cash flow did Caesarstone Ltd. generate in fiscal 2025?

Cash from operations of $38.0M minus capital expenditures of $9.0M left free cash flow of -$47.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Caesarstone Ltd.